Proximal Femoral Shortening After Cephalomedullary Nail Insertion for Intertrochanteric Fractures
OBJECTIVE:To assess the incidence of proximal femoral shortening (PFS) and its effect on the patient outcomes when intertrochanteric fractures were treated with a cephalomedullary nail (CMN). DESIGN:Retrospective cohort study. SETTINGS:Level II trauma center. PATIENTS:Forty-eight consecutive patient...
Gespeichert in:
Veröffentlicht in: | Journal of orthopaedic trauma 2017-06, Vol.31 (6), p.311-315 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | OBJECTIVE:To assess the incidence of proximal femoral shortening (PFS) and its effect on the patient outcomes when intertrochanteric fractures were treated with a cephalomedullary nail (CMN).
DESIGN:Retrospective cohort study.
SETTINGS:Level II trauma center.
PATIENTS:Forty-eight consecutive patients with OTA/AO 31-A intertrochanteric fractures.
INTERVENTION:All patients were treated with a Gamma3 CMN (Stryker, Kalamazoo, MI).
METHODS:PFS was assessed for abductor lever arm (x vector), femoral height (y vector), and overall shortening (z vector) on anteroposterior radiographs. Fixation success and retained ambulatory capacity were noted.
RESULTS:Shortening of >5 mm of the x, y, and z vectors was evident in 18, 20, and 29 patients, respectively. Shortening of >10 mm of the x, y, and z vectors was measured in 5, 6, and 8 patients, respectively. Mean shortening of the x, y, and z vectors was 4.5, 5.5, and 7 mm, respectively. Greater PFS was found to be associated with fixation failure and inability to retain ambulatory capacity, independently (P ≤ 0.05 and P ≤ 0.025, respectively). Of note, an unstable fracture pattern was not found to be associated with greater PFS.
CONCLUSIONS:PFS is a common phenomenon after CMN of intertrochanteric fractures with a Gamma CMN. In addition, greater PFS seems to be associated with fixation failure and inability to retain ambulatory capacity postoperatively.
LEVEL OF EVIDENCE:Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence. |
---|---|
ISSN: | 0890-5339 1531-2291 |
DOI: | 10.1097/BOT.0000000000000835 |